Product Information
SODIUM CHLORIDE 0.9% SOLUTION is a generic product labeled by Nephron Pharmaceuticals Corporation, priced at $0.0262 per ML under NDC 00487430110. Its NADAC has been published 70 times since Mar 19, 2025.
FDA first approved this application on Apr 23, 2020. Its Orange Book therapeutic-equivalence code is AP.
Strength
9 mg/mL
Manufacturer
Nephron Pharmaceuticals CorporationNDC
00487430110
Classification
Generic
Dosage Form
INJECTION
Route
INTRAVENOUS
Effective Date
7/23/2025
Active Ingredients
SODIUM CHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA211968FDA Approved
4/23/2020
TE Code
AP
On Market Since
6/4/2020
Price Statistics
The NADAC for SODIUM CHLORIDE 0.9% SOLUTION has been published 70 times since Mar 19, 2025, and over the history we have for it it has risen 2.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0262 per ML |
|---|---|
| All-time high | $0.0262 (Jul 15, 2026) |
| All-time low | $0.0257 (Mar 19, 2025) |
| 52-week high | $0.0262 |
| 52-week low | $0.0262 |
| Median price | $0.0262 |
| Average price | $0.0261 |
| Largest weekly change | +1.1% (May 21, 2025) |
| Weeks tracked | 70 |
| Tracking since | Mar 19, 2025 |
1W
N/A
1M
N/A
3M
0.0%
6M
0.0%
1Y
0.0%
3Y
N/A
5Y
N/A
All
+2.2%
Last surveyed Jul 15, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 92% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Nephron Pharmaceuticals Corporation manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Sodium Chloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SODIUM CHLORIDE 0.9% SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for SODIUM CHLORIDE 0.9% SOLUTION, manufactured by Nephron Pharmaceuticals Corporation, is $0.0262 per ML (NDC 00487430110), effective Jul 15, 2026.
How has the price of SODIUM CHLORIDE 0.9% SOLUTION changed over time?
Over the history we have for it, the NADAC for SODIUM CHLORIDE 0.9% SOLUTION has risen 2.2%. It has been tracked across 70 weekly CMS publications since Mar 19, 2025.
What are the highest and lowest recorded NADAC prices for SODIUM CHLORIDE 0.9% SOLUTION?
Since Mar 19, 2025, the NADAC for SODIUM CHLORIDE 0.9% SOLUTION has ranged from a low of $0.0257 (Mar 19, 2025) to a high of $0.0262 (Jul 15, 2026), with a median of $0.0262 per ML.
Are there cheaper alternatives to SODIUM CHLORIDE 0.9% SOLUTION?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SODIUM CHLORIDE 0.9% SOLUTION, is $0.0021 per ML — about 92% below SODIUM CHLORIDE 0.9% SOLUTION.
Who manufactures SODIUM CHLORIDE 0.9% SOLUTION?
SODIUM CHLORIDE 0.9% SOLUTION (NDC 00487430110) is labeled by Nephron Pharmaceuticals Corporation, and CMS classifies it as a generic product.